No Prescription |
 |
 | ||
|
Zantac Generic Ranitidine |
|
| ||
No Prescription » Prescription Drugs 17 » Zantac Generic Ranitidine Product Origin: EU (Turkey)This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.Medical Information:Zantac is used for: Treating certain types of ulcers and other stomach conditions. Ranitidine works by reducing the amount of acid your stomach produces. Ranitidine is used to treat and prevent ulcers in the stomach and intestines. It also treats conditions in which the stomach produces too much acid. Zantac is used to decrease the production of stomach acid which may reduce irritation to the stomach lining and help heal ulcers and other gastrointestinal conditions. It's prescribed for the following:Short-term treatment (4 to 8 weeks) of active ulcers specifically duodenal ulcers or benign stomach ulcers (also called gastric ulcers). Maintenance therapy (at a reduced dosage) to help keep the ulcer from coming back after it has healed. Treatment of conditions in which the stomach produces too much acid such as Zollinger-Ellison syndrome and systemic mastocytosis. Treatment of gastroesophageal reflux disease (also known as GERD which occurs when stomach acid backs up into the esophagus). Treating and maintaining healing of erosive esophagitis (severe inflammation of the esophagus). Over-the-counter versions of Zantac are also available for relieving and preventing heartburn associated with acid indigestion and sour stomach. Buy Zantac Generic Ranitidine and other Prescription Drugs 17 products online at Medstore. Buy Online at Medstore - Click Here!
About Zantac Generic Ranitidine: Product Type: Prescription Drugs 17 Zantac ( Generic Ranitidine ) Zantac (Generic Ranitidine) Generic Ranitidine 300mg Generic Ranitidine Zantac
View more Prescription Drugs 17 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
